story of the week
Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Open-Label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer
JAMA Oncol 2019 Jun 13;[EPub Ahead of Print], S Vinayak, SM Tolaney, L Schwartzberg, M Mita, G McCann, AR Tan, AE Wahner-Hendrickson, A Forero, C Anders, GM Wulf, P Dillon, F Lynce, C Zarwan, JK Erban, Y Zhou, N Buerstatte, JR Graham, S Arora, BJ Dezube, ML TelliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.